WEST PHARMACEUTICAL SERVICES, INC. Cost-method Investments, Other than Temporary Impairment
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Cost-method Investments, Other than Temporary Impairment of $800.00 thousand for the 12-month period ending 2009-12-31, per its 10-K/A filed 2012-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2012-03-01
- WEST PHARMACEUTICAL SERVICES, INC. cost-method investments, other than temporary impairment for fiscal 2009 was $800.00K.
| Period end | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|
| 2009-12-31 | $800.00K 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |